These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis. Dorneburg C; Fischer M; Barth TFE; Mueller-Klieser W; Hero B; Gecht J; Carter DR; de Preter K; Mayer B; Christner L; Speleman F; Marshall GM; Debatin KM; Beltinger C Clin Cancer Res; 2018 Nov; 24(22):5772-5783. PubMed ID: 29925504 [No Abstract] [Full Text] [Related]
3. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma. Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046 [TBL] [Abstract][Full Text] [Related]
4. Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Qing G; Skuli N; Mayes PA; Pawel B; Martinez D; Maris JM; Simon MC Cancer Res; 2010 Dec; 70(24):10351-61. PubMed ID: 20961996 [TBL] [Abstract][Full Text] [Related]
5. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma. Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807 [TBL] [Abstract][Full Text] [Related]
6. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells. O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962 [TBL] [Abstract][Full Text] [Related]
7. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746 [TBL] [Abstract][Full Text] [Related]
8. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Vandesompele J; Edsjö A; De Preter K; Axelson H; Speleman F; Påhlman S Oncogene; 2003 Jan; 22(3):456-60. PubMed ID: 12545167 [TBL] [Abstract][Full Text] [Related]
9. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613 [TBL] [Abstract][Full Text] [Related]
10. Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice. Huang CC; Wang SY; Lin LL; Wang PW; Chen TY; Hsu WM; Lin TK; Liou CW; Chuang JH Dis Model Mech; 2015 Oct; 8(10):1247-54. PubMed ID: 26398947 [TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation. Puppo M; Pastorino S; Melillo G; Pezzolo A; Varesio L; Bosco MC Clin Cancer Res; 2004 Dec; 10(24):8704-19. PubMed ID: 15623656 [TBL] [Abstract][Full Text] [Related]
12. NCYM promotes calpain-mediated Myc-nick production in human MYCN-amplified neuroblastoma cells. Shoji W; Suenaga Y; Kaneko Y; Islam SM; Alagu J; Yokoi S; Nio M; Nakagawara A Biochem Biophys Res Commun; 2015 Jun; 461(3):501-6. PubMed ID: 25896758 [TBL] [Abstract][Full Text] [Related]
13. MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells. Cortés C; Kozma SC; Tauler A; Ambrosio S Cell Oncol (Dordr); 2015 Oct; 38(5):341-52. PubMed ID: 26306783 [TBL] [Abstract][Full Text] [Related]
14. MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent. Wang T; Liu L; Chen X; Shen Y; Lian G; Shah N; Davidoff AM; Yang J; Wang R Cell Death Dis; 2018 Feb; 9(2):220. PubMed ID: 29445162 [TBL] [Abstract][Full Text] [Related]
15. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells. Smith AG; Popov N; Imreh M; Axelson H; Henriksson M J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910 [TBL] [Abstract][Full Text] [Related]
16. Targeting of the MYCN protein with small molecule c-MYC inhibitors. Müller I; Larsson K; Frenzel A; Oliynyk G; Zirath H; Prochownik EV; Westwood NJ; Henriksson MA PLoS One; 2014; 9(5):e97285. PubMed ID: 24859015 [TBL] [Abstract][Full Text] [Related]
17. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2. Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759 [TBL] [Abstract][Full Text] [Related]
18. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells. Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177 [TBL] [Abstract][Full Text] [Related]
19. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Kang JH; Rychahou PG; Ishola TA; Qiao J; Evers BM; Chung DH Biochem Biophys Res Commun; 2006 Dec; 351(1):192-7. PubMed ID: 17055458 [TBL] [Abstract][Full Text] [Related]
20. Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma. Cabanillas Stanchi KM; Bruchelt G; Handgretinger R; Holzer U Cancer Biol Ther; 2015; 16(9):1353-63. PubMed ID: 26177922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]